NEXGEL
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2150 Cabot Blvd W Ste B, Langhorne, Penn...Phone Number
(215) 702-8550Website
www.nexgel.comRevenue
$11.3 MillionStock Symbol
NXGLIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About NEXGEL
NEXGEL is a healthcare and materials science company that develops and manufactures advanced hydrogel-based patches and transdermal delivery systems used in wound care, cosmetics, and over-the-counter medical applications. The company specializes in electron-beam cross-linked hydrogel technology designed to deliver active ingredients gently to the skin without traditional chemical adhesives. Its products are used across medical, cosmetic, and consumer health markets, focusing on skin-friendly, high-water-content materials for therapeutic and commercial applications.Explore more
NEXGEL Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NEXGEL your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on NEXGEL recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if NEXGEL had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at NEXGEL
Funding: Get notified immidiatlly once NEXGEL has new funding data
Check if NEXGEL has recently received funding, and reach out quickly before it becomes old news!
NEXGEL, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if NEXGEL is spiking on competitors!
Product Launch: Get notified when NEXGEL launches new products
Recommended Actions
Find VP level buyers at NEXGEL
Find 3 more new buyers
Compare Similar Companies to NEXGEL
Compare insights from companies similar to NEXGEL, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NEXGEL is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NEXGEL is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NEXGEL.
NEXGEL financials insights
Gather financial insights about NEXGEL, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$127K
2022
Stock Offering
$14.2M
2026
Stock/Share Issuance
$1.2M
NEXGEL Tech Stack
A closer look at the technologies used by NEXGEL
See more technologies
Most Recent Scoops
Project
NEXGEL has announced the publication of a clinical study, sponsored by Innovative Optics, demonstrating a 96% reduction in surgical plume, with secondary endpoints showing reduced pain and approximately 7% efficacy improvement, with Innovative Optics now beginning marketing efforts leveraging the study results.
Marketing Campaign, Clinical Operations
Earnings
NEXGEL has reported revenue of $2.65 million for Q1, missing the prior year figure of $2.81 million for the same period, reflecting a year-over-year decline. The decrease was driven primarily by lower sales from the Silly George brand, partially offset by revenue growth in contract manufacturing and the MEDAGEL brand.
Earnings, Finance
Pain Point
NEXGEL has reported that its Silly George brand experienced an exceptionally poor Q4, with new product launches such as lip gloss underperforming expectations amid heightened competition, though the company has since repositioned the brand and is reporting a return to growth in April.
Product Marketing, Product Launch
Project
currently has three 510(k) devices in development within its pipeline, representing approximately $4.6 million in invested paid-in capital, with commercialization targeted for 2026, 2027, and 2028 respectively.
Spending/Investment, Product Development
Management Move
Board of Directors
NEXGEL News & Media
NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration
The study concluded that NEXGEL’s hydrogel patch significantly reduced laser plume generation and exposure during laser hair removal and the patch was associated with greater hair reduction and reduced pain compared to the controlNexGel Raises $1.21 Million Via Convertible Notes and Warrants; $0.60 Conversion, $0.80 Exercise
NexGel secured $1.21 million in a private placement of unsecured convertible promissory notes and warrants with accredited investors, setting an initial note conversion price of $0.60 per share and a warrant exercise price of $0.80 for 1,008,334 shares, with warrants expiring five years from issuan…NEXGEL To Report First Quarter 2026 Financial Results on May 15th
Management Will Host a Conference Call at 12:00 P.M. ET on the Same DayNEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors
Sequence LifeScienceTM Led Financing to Close on Acquisition of Celularity with Strategic Investment of $5.5 Million
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NEXGEL
Sign Up For FreeTo access detailed company insights
NEXGEL is a healthcare and materials science company that develops and manufactures advanced hydrogel-based patches and transdermal delivery systems used in wound care, cosmetics, and over-the-counter medical applications. The company specializes in electron-beam cross-linked hydrogel technology designed to deliver active ingredients gently to the... Read More
